Completed cardiovascular outcomes trials have demonstrated statistically significant reductions in major adverse cardiovascular events (MACE) in high-risk populations, making it the reference compound for cardiovascular metabolic research [2][3]
Beyond Basal Insulin When treatment is intensified beyond basal insulin therapy, a number of factors should be taken into account as part of the shared decision-making process, such as patient preference, safety, tolerability, glycemic efficacy, risk of hypoglycemia, and other non-glycemic effects (e.g., weight change and/or impact on life-style) [13]
Il participe aussi restaurer laction anti-oxydant de la vitamine E
However, even with these strategies, plasma concentrations of free parent compounds rarely reach those used in typical in vitro experiments (56)